Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Jan. 4, 2018. Justin Barad.

Executive Summary

Check out what Osso VR CEO – and pediatric orthopedic surgeon – Justin Barad had to say about how patient preference could boost interest in minimally invasive knee and hip arthroplasties.

"In general, to this point, minimally invasive knee and hip arthroplasties haven't shown much of a difference in outcome. But there is another factor to consider, and that is patient preference. If a patient can have a smaller incision or if a surgery is even perceived to be more minimally invasive, those can become very popular, as in the case of anterior total hip arthroplasty, which has really exploded in popularity in recent years despite some mixed data on improved outcomes compared with traditional posterior approaches." –Justin Barad, pediatric orthopedic surgeon & founder and CEO, Osso VR

> Find out more: EU Ortho Close-Up: Rising, But Varying Orthopedic/Spinal Opportunities In 5 European Markets

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel